NCT05155072View on ClinicalTrials.gov

Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

September 7, 2020

Study Completion Date

September 7, 2020

Conditions
Gastritis
Interventions
DRUG

DW1903

DW1903

DRUG

DW1903-R1

DW1903-R1

DRUG

DW1903-R2

DW1903-R2

Trial Locations (1)

Unknown

Chungbuk National University Hospital, Cheongju-si

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY

NCT05155072 - Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903 | Biotech Hunter | Biotech Hunter